Physician profile
Mark Logan
NPI 1720077407
$3,166.07
in general payments reported to CMS, 2019-2025
19 companies · $729 in 2025
The $729 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $56.19 · 2021: $503 · 2022: $460 · 2023: $337 · 2024: $609 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,676.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $794.44 | 2021-2025 | Dupixent |
| Genzyme Corporation | $730.94 | 2019-2025 | |
| Inspire Medical Systems, INC. | $376.62 | 2022-2025 | Inspire |
| Acclarent, INC | $288.89 | 2019-2023 | Relieva Spinplus |
| Stryker Corporation | $281.35 | 2019-2022 | |
| Intersect Ent, INC. | $134.43 | 2019 | |
| Optinose US, INC. | $133.17 | 2019-2022 | |
| Glaxosmithkline, LLC. | $94.24 | 2023-2025 | Nucala |
| Tactile Systems Technology INC | $60.90 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $60.50 | 2019-2021 | |
| Itamar Medical INC | $35.49 | 2024 | Watchpatone |
| Kowa Pharmaceuticals America, INC. | $32.94 | 2022 | |
| Alk-Abello, INC | $28.47 | 2021-2025 | Alternaria Tenuis, Pre-Pen, Standardized Mite D. Farinae |
| Hologic Sales and Service, LLC | $23.22 | 2023 | Coolseal Generator |
| Integra Lifesciences Corporation | $21.68 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $20.93 | 2021 | |
| Surgenex LLC | $19.07 | 2025 | Pellograft, Surmatrix, Surgraft |
| Merck Sharp & Dohme LLC | $14.44 | 2021 | |
| Hikma Pharmaceuticals USA | $14.35 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.